InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: Money $hot post# 13380

Friday, 01/22/2021 4:17:45 PM

Friday, January 22, 2021 4:17:45 PM

Post# of 16706
AGN has initially stated the business model as developing the drug, not extended production. Securing 40M doses seems part of the EUA requirement besides suppling the Trials.
Good data may lead to a deal, IMO. If needed maybe raising $10M+ for Phase 3 finances can now be done at a much better Price. The warrants should have supplied enough for the analysis and presentations and-or a flight and hotel near Johnson and Johnson...GLTA...